Mesenchymal stem cell-released oncolytic virus: an innovative strategy for cancer treatment
Nadia Ghasemi Darestani(Isfahan University of Medical Sciences), Reza Akhavan‐Sigari(Medical University of Warsaw), Yasser Fakri Mustafa(University of Mosul), Saif A. J. Al-Shalah(Alsalam University College), Mohammed Abed Jawad(Al-Nisour University College), Mohammad Javed Ansari(Prince Sattam Bin Abdulaziz University), Jasur Rizaev(Samarkand State Medical Institute), Naseer Mihdi Mohammed(Mazaya University College), Mohammad Darvishi(Aja University of Medical Sciences), Yasir S. Alnassar, Rahman S. Zabibah(Iraqi University), Angelina Olegovna Zekiy(Sechenov University), Anna I. Gilmanova(Sechenov University), Moaed E. Al‐Gazally(University of Kerbala)
Cited by 66
Related Papers
Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation
|Molecular Cancer|2023|956
Clinical application of mesenchymal stem cell in regenerative medicine: a narrative review
|Stem Cell Research & Therapy|2022|404
RETRACTED ARTICLE: Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders
|Stem Cell Research & Therapy|2021|275
Recent progressions in biomedical and pharmaceutical applications of chitosan nanoparticles: A comprehensive review
|International Journal of Biological Macromolecules|2023|128